应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01681 康臣药业
休市中 05-09 16:08:07
9.540
-0.170
-1.75%
最高
9.710
最低
9.450
成交量
106.30万
今开
9.710
昨收
9.710
日振幅
2.68%
总市值
81.19亿
流通市值
81.19亿
总股本
8.51亿
成交额
1,015万
换手率
0.12%
流通股本
8.51亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
康臣药业(01681):益肾化湿颗粒获批准为中药二级保护品种
智通财经 · 04-30
康臣药业(01681):益肾化湿颗粒获批准为中药二级保护品种
康臣药业04月30日主力净流出160.9万元 散户资金买入
市场透视 · 04-30
康臣药业04月30日主力净流出160.9万元 散户资金买入
康臣药业:收到SK-09片临床试验批准通知书
格隆汇 · 04-25
康臣药业:收到SK-09片临床试验批准通知书
康臣药业(01681)收到SK-09片的《药物临床试验批准通知书》
智通财经 · 04-25
康臣药业(01681)收到SK-09片的《药物临床试验批准通知书》
康臣药业获FMR LLC增持51.4万股
格隆汇资讯 · 04-16
康臣药业获FMR LLC增持51.4万股
康臣药业03月10日主力净流入66万元 散户资金抛售
市场透视 · 03-10
康臣药业03月10日主力净流入66万元 散户资金抛售
康臣药业3月26日举行董事局会议审阅及批准年度业绩
格隆汇 · 03-05
康臣药业3月26日举行董事局会议审阅及批准年度业绩
康臣药业03月04日获主力加仓203万元
市场透视 · 03-04
康臣药业03月04日获主力加仓203万元
康臣药业董事局成员及财务总监发生变动
财中社 · 02-24
康臣药业董事局成员及财务总监发生变动
康臣药业(01681):李灼光获委任为独立非执行董事
智通财经 · 02-24
康臣药业(01681):李灼光获委任为独立非执行董事
康臣药业(01681.HK)1月15日收盘下跌0.53%,成交1447.67万港元
金融界 · 01-15
康臣药业(01681.HK)1月15日收盘下跌0.53%,成交1447.67万港元
康臣药业01月10日遭主力抛售50万元 环比增加212.50%
市场透视 · 01-10
康臣药业01月10日遭主力抛售50万元 环比增加212.50%
康臣药业01月09日主力资金流出16万元 连续3日减仓
市场透视 · 01-09
康臣药业01月09日主力资金流出16万元 连续3日减仓
康臣药业01月03日主力资金流出38万元 连续3日减仓
市场透视 · 01-03
康臣药业01月03日主力资金流出38万元 连续3日减仓
康臣药业01月02日遭主力抛售160万元 环比增加788.89%
市场透视 · 01-02
康臣药业01月02日遭主力抛售160万元 环比增加788.89%
年度盘点|2024年的港股医药生物公司跌多涨少,涨跌幅最大前十公司分别有何共性
第一财经 · 01-01
年度盘点|2024年的港股医药生物公司跌多涨少,涨跌幅最大前十公司分别有何共性
康臣药业12月31日遭主力抛售52万元 环比增加188.89%
市场透视 · 2024-12-31
康臣药业12月31日遭主力抛售52万元 环比增加188.89%
康臣药业盘中异动 大幅拉升5.00%报8.190港元
市场透视 · 2024-12-30
康臣药业盘中异动 大幅拉升5.00%报8.190港元
康臣药业(01681)股价上升5.128%,现价港币$8.2
阿斯达克财经 · 2024-12-30
康臣药业(01681)股价上升5.128%,现价港币$8.2
康臣药业12月17日遭主力抛售227万元 环比增加3142.86%
市场透视 · 2024-12-17
康臣药业12月17日遭主力抛售227万元 环比增加3142.86%
加载更多
公司概况
公司名称:
康臣药业
所属市场:
SEHK
上市日期:
--
主营业务:
康臣药业集团有限公司是一家主要从事药品生产及销售业务的公司。该公司通过两个部门开展业务。康臣药业分部主要从事生产及销售现代中成药及医用成像对比剂业务。玉林制药分部主要从事生产及销售传统中成药业务。该公司的产品主要包括肾科药物、妇儿药物、对比剂、骨科药物、皮肤科药物、肝胆药物和其他。该公司主要在中国国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01681","market":"HK","secType":"STK","nameCN":"康臣药业","latestPrice":9.54,"timestamp":1746778087015,"preClose":9.71,"halted":0,"volume":1063000,"delay":0,"floatShares":851000000,"shares":851000000,"eps":1.191261256645016,"marketStatus":"休市中","change":-0.17,"latestTime":"05-09 16:08:07","open":9.71,"high":9.71,"low":9.45,"amount":10151360,"amplitude":0.026777,"askPrice":9.54,"askSize":24000,"bidPrice":9.49,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":1.171032476371981,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747013400000},"marketStatusCode":7,"adr":0,"listingDate":1387382400000,"exchange":"SEHK","adjPreClose":9.71,"dividendRate":0.09434,"openAndCloseTimeList":[[1746754200000,1746763200000],[1746766800000,1746777600000]],"volumeRatio":0.5237810388410746,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01681","defaultTab":"news","newsList":[{"id":"2531702400","title":"康臣药业(01681):益肾化湿颗粒获批准为中药二级保护品种","url":"https://stock-news.laohu8.com/highlight/detail?id=2531702400","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531702400?lang=zh_cn&edition=full","pubTime":"2025-04-30 16:54","pubTimestamp":1746003276,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康臣药业(01681)发布公告,于2025年4月28日,国家药品监督管理局发布《中药保护品种公告(第25号 )( 2025年第45号)》,其中载列集团的产品益肾化湿颗粒(该产品)已根据《中药品种保护条例》获批准为中药二级保护品种,公司的全资附属公司广州康臣药业有限公司(广州康臣)获颁《中药保护品种证书》(该证书),证书号:(2025)国药中保证字第009号。该产品享有7年国家保护期,并可于进一步申请时重续。于保护期内,其他企业不得仿制该产品。于本公告日期,广州康臣为该产品及该证书的唯一持有人。董事会认为,有关认可是国家对该产品的支持,将有利于集团未来的长期发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288367.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业(01681):益肾化湿颗粒获批准为中药二级保护品种","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01681","BK1606"],"gpt_icon":0},{"id":"2531085158","title":"康臣药业04月30日主力净流出160.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2531085158","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531085158?lang=zh_cn&edition=full","pubTime":"2025-04-30 16:15","pubTimestamp":1746000946,"startTime":"0","endTime":"0","summary":"04月30日, 康臣药业股价跌2.53%,报收9.26元,成交金额1729.2万元,换手率0.22%,振幅3.37%,量比1.15。康臣药业今日主力资金净流出160.9万元,上一交易日主力净流入31.1万元。该股近5个交易日下跌5.24%,主力资金累计净流出171.4万元;近20日主力资金累计净流入1829.1万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430171226a6ce9ba2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430171226a6ce9ba2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01681","BK1191","BK1606"],"gpt_icon":0},{"id":"2530903570","title":"康臣药业:收到SK-09片临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2530903570","media":"格隆汇","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530903570?lang=zh_cn&edition=full","pubTime":"2025-04-25 17:00","pubTimestamp":1745571654,"startTime":"0","endTime":"0","summary":"格隆汇4月25日丨康臣药业(01681.HK)发布公告,公司已收到中国国家药品监督管理局签发的有关SK-09片的《药物临床试验批准通知书》。SK-09片为一类化学新药。根据披露,足细胞损伤相关肾脏疾病是一类以肾小球足细胞损伤为主要病理改变的肾脏疾病,包括糖尿病肾病、局灶节段性肾小球硬化、微小病变肾病等。患者常因得不到及时有效的治疗,最终进展为终末期肾病(ESRD),对患者本人、家庭及社会医疗造成沉重负担。目前临床上缺乏针对足细胞保护的靶向疗法,SK-09片的临床研发有望为肾脏病患者提供更为精准有效的治疗新选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042517005494e23a18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042517005494e23a18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","03347","BK1583","BK1191","01681","BK1606"],"gpt_icon":0},{"id":"2530777099","title":"康臣药业(01681)收到SK-09片的《药物临床试验批准通知书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2530777099","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530777099?lang=zh_cn&edition=full","pubTime":"2025-04-25 16:45","pubTimestamp":1745570700,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康臣药业(01681)公布,公司已收到中国国家药品监督管理局签发的有关SK-09片的《药物临床试验批准通知书》,SK-09片用于足细胞损伤相关肾脏疾病(糖尿病肾病、局灶节段性肾小球硬化及微小病变肾病等)的治疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1284952.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1141","03347","BK1576","01681","BK1606","BK1583"],"gpt_icon":0},{"id":"2528207143","title":"康臣药业获FMR LLC增持51.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2528207143","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528207143?lang=zh_cn&edition=full","pubTime":"2025-04-17 07:20","pubTimestamp":1744845632,"startTime":"0","endTime":"0","summary":"格隆汇4月17日丨根据联交所最新权益披露资料显示,2025年4月11日,康臣药业(01681.HK)获FMR LLC在场内以每股均价9.3233港元增持51.4万股,涉资约479.22万港元。增持后,FMR LLC最新持股数目为42,676,062股,持股比例由4.96%上升至5.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417072043973a6b6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417072043973a6b6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01681","BK1606","BK1191"],"gpt_icon":0},{"id":"2518967219","title":"康臣药业03月10日主力净流入66万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2518967219","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518967219?lang=zh_cn&edition=full","pubTime":"2025-03-10 16:16","pubTimestamp":1741594563,"startTime":"0","endTime":"0","summary":"03月10日, 康臣药业股价涨0.51%,报收7.96元,成交金额516万元,换手率0.08%,振幅3.66%,量比0.37。康臣药业今日主力资金净流入66万元,上一交易日主力净流出122万元。该股近5个交易日上涨4.06%,主力资金累计净流入457万元;近20日主力资金累计净流入331万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310170031a269ba24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310170031a269ba24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01681","BK1191","BK1606"],"gpt_icon":0},{"id":"2517995530","title":"康臣药业3月26日举行董事局会议审阅及批准年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2517995530","media":"格隆汇","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517995530?lang=zh_cn&edition=full","pubTime":"2025-03-05 16:57","pubTimestamp":1741165022,"startTime":"0","endTime":"0","summary":"格隆汇3月5日丨康臣药业此宣布,公司将于2025年3月26日(星期三)举行董事局会议,以处理以下事项:1.审阅及批准集团截至2024年12月31日止年度经审核综合财务报表;2.审阅及批准将根据香港联合交易所有限公司证券上市规则公布的集团年度业绩公告草案;3.考虑派发末期股息(如有);4.考虑召开公司应届股东周年大会的相关事宜;及5.考虑及批准其他事项(如有)。请读者仅作参考,并请自行承担全部责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305170254989ce34d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305170254989ce34d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01681","BK1191","BK1606"],"gpt_icon":0},{"id":"2516762513","title":"康臣药业03月04日获主力加仓203万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516762513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516762513?lang=zh_cn&edition=full","pubTime":"2025-03-04 17:39","pubTimestamp":1741081153,"startTime":"0","endTime":"0","summary":"03月04日, 康臣药业股价涨0.52%,报收7.68元,成交金额920万元,换手率0.14%,振幅2.75%,量比0.62。康臣药业今日主力资金净流入203万元,上一交易日主力净流入121万元。该股近5个交易日下跌3.16%,主力资金累计净流入43万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入74万元,其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304174709abe79433&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304174709abe79433&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01681","BK1191","BK1606"],"gpt_icon":0},{"id":"2513294712","title":"康臣药业董事局成员及财务总监发生变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2513294712","media":"财中社","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513294712?lang=zh_cn&edition=full","pubTime":"2025-02-24 16:38","pubTimestamp":1740386328,"startTime":"0","endTime":"0","summary":"2月24日,康臣药业(01681)发布公告,自2025年2月24日起,董事局成员及财务总监发生变动。公告中提到,独立非执行董事陈玉君辞任,并不再担任审计委员会、提名委员会、薪酬委员会及环境、社会及治理委员会的成员。同时,李灼光被任命为新的独立非执行董事及审计委员会主席,接替陈玉君的职位。此外,方培城不再兼任财务总监职务,继续担任集团副总裁。陈玉君被任命为新的财务总监。陈玉君自2019年5月31日起担任独立非执行董事,具备相应的专业资格及会计知识。此次变动将有助于公司管理层的职能重新分配,并确保公司的持续发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224163914962e3878&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224163914962e3878&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01681","BK1191","BK1606"],"gpt_icon":0},{"id":"2513121757","title":"康臣药业(01681):李灼光获委任为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2513121757","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513121757?lang=zh_cn&edition=full","pubTime":"2025-02-24 16:34","pubTimestamp":1740386070,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康臣药业(01681)发布公告,自2025年2月24日起生效:陈玉君女士已辞任独立非执行董事,且不再为审核委员会主席以及提名委员会、薪酬委员会及ESG委员会各自的成员;李灼光先生已获委任为独立非执行董事、审核委员会主席以及提名委员会、薪酬委员会及ESG委员会各自的成员;方培城先生不再兼任财务总监;陈玉君女士已获委任为财务总监。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1253398.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01681","BK1606","BK1191"],"gpt_icon":0},{"id":"2503937691","title":"康臣药业(01681.HK)1月15日收盘下跌0.53%,成交1447.67万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503937691","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503937691?lang=zh_cn&edition=full","pubTime":"2025-01-15 16:53","pubTimestamp":1736931224,"startTime":"0","endTime":"0","summary":"1月15日,截至港股收盘,恒生指数上涨0.34%,报19286.07点。康臣药业收报7.5港元/股,下跌0.53%,成交量193.72万股,成交额1447.67万港元,振幅3.05%。最近一个月来,康臣药业累计跌幅3.33%,今年来累计跌幅7.48%,跑输恒生指数-4.19%的跌幅。财务数据显示,截至2024年6月30日,康臣药业实现营业总收入12.69亿元,同比增长13.3%;归母净利润4亿元,同比增长14.91%;毛利率74.69%,资产负债率27.3%。2023年,康臣药业集团位列“2022年度中药企业TOP100排行榜”第22位,品牌价值达112.36亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/15165347480219.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01681","BK1606","BK1191"],"gpt_icon":0},{"id":"2502412869","title":"康臣药业01月10日遭主力抛售50万元 环比增加212.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502412869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502412869?lang=zh_cn&edition=full","pubTime":"2025-01-10 16:16","pubTimestamp":1736496988,"startTime":"0","endTime":"0","summary":"01月10日, 康臣药业股价涨1.06%,报收7.60元,成交金额771万元,换手率0.12%,振幅1.99%,量比0.80。康臣药业今日主力资金净流出50万元,连续4日净流出,上一交易日主力净流出16万元,今日环比增加212.50%。近一年数据显示,该股主力连续4日净流出后,次日下跌概率为28.57%,平均跌幅为0.57%。该股近5个交易日下跌4.52%,主力资金累计净流出190万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出909万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110161701a21ca35a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110161701a21ca35a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1606","01681"],"gpt_icon":0},{"id":"2502060466","title":"康臣药业01月09日主力资金流出16万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2502060466","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502060466?lang=zh_cn&edition=full","pubTime":"2025-01-09 16:16","pubTimestamp":1736410567,"startTime":"0","endTime":"0","summary":"01月09日, 康臣药业股价涨1.35%,报收7.52元,成交金额1365万元,换手率0.21%,振幅3.23%,量比1.61。康臣药业今日主力资金净流出16万元,连续3日净流出,上一交易日主力净流出94万元,今日环比减少82.98%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为50.00%,平均跌幅为1.28%。该股近5个交易日下跌7.06%,主力资金累计净流出179万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出859万元,其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109161637aba44083&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109161637aba44083&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1606","01681","BK1191"],"gpt_icon":0},{"id":"2500161349","title":"康臣药业01月03日主力资金流出38万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2500161349","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500161349?lang=zh_cn&edition=full","pubTime":"2025-01-03 16:15","pubTimestamp":1735892124,"startTime":"0","endTime":"0","summary":"01月03日, 康臣药业股价跌1.36%,报收7.96元,成交金额534万元,换手率0.08%,振幅3.22%,量比0.53。康臣药业今日主力资金净流出38万元,连续3日净流出,上一交易日主力净流出160万元,今日环比减少76.25%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为54.55%,平均跌幅为1.28%。该股近5个交易日上涨2.57%,主力资金累计净流出216万元;近20日主力资金累计净流出682万元,其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103161543ab9cea78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103161543ab9cea78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1606","BK1191","01681"],"gpt_icon":0},{"id":"2500291167","title":"康臣药业01月02日遭主力抛售160万元 环比增加788.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500291167","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500291167?lang=zh_cn&edition=full","pubTime":"2025-01-02 16:15","pubTimestamp":1735805745,"startTime":"0","endTime":"0","summary":"01月02日, 康臣药业股价跌0.98%,报收8.07元,成交金额941万元,换手率0.14%,振幅2.82%,量比1.08。康臣药业今日主力资金净流出160万元,上一交易日主力净流出18万元,今日环比增加788.89%。该股近5个交易日上涨5.45%,主力资金累计净流出178万元;近20日主力资金累计净流出445万元,其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102161610ab9b8148&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102161610ab9b8148&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01681","BK1606"],"gpt_icon":0},{"id":"2500988151","title":"年度盘点|2024年的港股医药生物公司跌多涨少,涨跌幅最大前十公司分别有何共性","url":"https://stock-news.laohu8.com/highlight/detail?id=2500988151","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500988151?lang=zh_cn&edition=full","pubTime":"2025-01-01 18:21","pubTimestamp":1735726876,"startTime":"0","endTime":"0","summary":"刚刚过去的2024年,港股医药生物市场中的106只个股,股价(后复权)累计实现上涨的有26只,占比约25%。这里的医药生物市场,囊括了化学制药、中药、生物制品、医药商业、医疗器械、医疗服务这些细分市场。从涨幅最大或者跌幅最大的前十只个股来看,均以18A药企(港交所18A规则上市的公司)为主。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202501013284563250.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202501013284563250.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1794554557.SGD","02877","LU0348784397.USD","BK1585","BK1574","09877","LU2488822045.USD","LU0196878994.USD","BK1100","02511","06185","01681","BK1606","09995","LU0348783233.USD","01167","03933","LU0417516571.SGD","06998","09886","LU1969619763.USD","BK1247","BK1161","09939","YANG","02407","IE00BPRC5H50.USD","LU1720050803.USD","01541","01952","02171","09926","HSCEI","IE00B5MMRT66.SGD","06855","LU2328871848.SGD","BK1189","06996","07226","BK1515","IE00B543WZ88.USD","02257","06990","02415","BK1191","BK1587","HSTECH","BK1583","BK1142"],"gpt_icon":0},{"id":"2495668575","title":"康臣药业12月31日遭主力抛售52万元 环比增加188.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495668575","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495668575?lang=zh_cn&edition=full","pubTime":"2024-12-31 16:16","pubTimestamp":1735632995,"startTime":"0","endTime":"0","summary":"12月31日, 康臣药业股价跌0.12%,报收8.15元,成交金额1241万元,换手率0.18%,振幅3.92%,量比1.87。康臣药业今日主力资金净流出52万元,上一交易日主力净流出18万元,今日环比增加188.89%。该股近5个交易日上涨4.62%,主力资金累计净流出70万元;近20日主力资金累计净流出337万元,其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231161717a210230f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231161717a210230f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1606","BK1191","01681"],"gpt_icon":0},{"id":"2495561686","title":"康臣药业盘中异动 大幅拉升5.00%报8.190港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495561686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495561686?lang=zh_cn&edition=full","pubTime":"2024-12-30 11:49","pubTimestamp":1735530561,"startTime":"0","endTime":"0","summary":"2024年12月30日临近午盘11时49分,康臣药业股票出现异动,股价快速上涨5.00%。截至发稿,该股报8.190港元/股,成交量68.6万股,换手率0.08%,振幅4.49%。康臣药业股票所在的药品行业中,整体涨幅为0.04%。其相关个股中,草姬集团、康臣药业、凯莱英涨幅较大,振幅较大的相关个股有草姬集团、中国医疗集团、德琪医药-B,振幅分别为12.77%、10.53%、9.09%。康臣药业分部主要从事生产及销售现代中成药及医用成像对比剂业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230114921ab97757f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230114921ab97757f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1606","01681","BK1191"],"gpt_icon":0},{"id":"2495561923","title":"康臣药业(01681)股价上升5.128%,现价港币$8.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2495561923","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495561923?lang=zh_cn&edition=full","pubTime":"2024-12-30 11:49","pubTimestamp":1735530540,"startTime":"0","endTime":"0","summary":"[上升股]康臣药业(01681) 股价在上午11:49比前收市价上升5.128%,现股价为港币$8.2。至目前为止,今日最高价为$8.2,而最低价为$7.85。总成交量为56.4万股,总成交金额为港币$451.024万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR241230788/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","01681","BK1606"],"gpt_icon":0},{"id":"2492993363","title":"康臣药业12月17日遭主力抛售227万元 环比增加3142.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492993363","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492993363?lang=zh_cn&edition=full","pubTime":"2024-12-17 16:16","pubTimestamp":1734423365,"startTime":"0","endTime":"0","summary":"12月17日, 康臣药业股价涨1.83%,报收7.78元,成交金额2144万元,换手率0.33%,振幅2.36%,量比1.91。康臣药业今日主力资金净流出227万元,连续3日净流出,上一交易日主力净流出7万元,今日环比增加3142.86%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为45.45%,平均跌幅为2.00%。该股近5个交易日下跌4.54%,主力资金累计净流出904万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入373万元,其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217161642ab7e9360&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217161642ab7e9360&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1606","BK1191","01681"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinaconsun.com","stockEarnings":[{"period":"1week","weight":-0.0104},{"period":"1month","weight":0.0829},{"period":"3month","weight":0.155},{"period":"6month","weight":0.1093},{"period":"1year","weight":0.7601},{"period":"ytd","weight":0.1706}],"compareEarnings":[{"period":"1week","weight":0.0161},{"period":"1month","weight":0.1285},{"period":"3month","weight":0.0821},{"period":"6month","weight":0.1032},{"period":"1year","weight":0.2336},{"period":"ytd","weight":0.14}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康臣药业集团有限公司是一家主要从事药品生产及销售业务的公司。该公司通过两个部门开展业务。康臣药业分部主要从事生产及销售现代中成药及医用成像对比剂业务。玉林制药分部主要从事生产及销售传统中成药业务。该公司的产品主要包括肾科药物、妇儿药物、对比剂、骨科药物、皮肤科药物、肝胆药物和其他。该公司主要在中国国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.583333,"avgChangeRate":0.036247},{"month":2,"riseRate":0.583333,"avgChangeRate":0.018608},{"month":3,"riseRate":0.5,"avgChangeRate":0.024862},{"month":4,"riseRate":0.75,"avgChangeRate":0.066512},{"month":5,"riseRate":0.583333,"avgChangeRate":0.025799},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.005424},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.031185},{"month":8,"riseRate":0.545455,"avgChangeRate":0.006611},{"month":9,"riseRate":0.545455,"avgChangeRate":0.015113},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.017287},{"month":11,"riseRate":0.545455,"avgChangeRate":0.010605},{"month":12,"riseRate":0.545455,"avgChangeRate":0.018424}],"exchange":"SEHK","name":"康臣药业","nameEN":"CONSUN PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康臣药业(01681)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康臣药业(01681)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康臣药业,01681,康臣药业股票,康臣药业股票老虎,康臣药业股票老虎国际,康臣药业行情,康臣药业股票行情,康臣药业股价,康臣药业股市,康臣药业股票价格,康臣药业股票交易,康臣药业股票购买,康臣药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康臣药业(01681)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康臣药业(01681)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}